One major thrust in radiology today is imaging standardization with rapidly acquired quantitative multi-contrast information. This is critical for multi-center trials, for the collection of big data and the use of artificial intelligence in evaluating the data. STAGE is one such method that can provide more than ten qualitative and quantitative pieces of information in roughly 5 minutes or less at 3T. In this work, we introduce several new image contrasts derived from STAGE and validate STAGE T1 mapping using the ISMRM/NIST phantom as well as in vivo data. We also present some preliminary pathological results.
This abstract and the presentation materials are available to members only; a login is required.